Panel Discussion

Monday, March 9, 2026

11:40 AM - 12:00 PM EST

Location: Spotlight Theater

Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

Disclosure(s): No financial relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Daniel Burkhoff, MD, PhD

Director: Heart Failure, Hemodynamics and MCS Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Navin K. Kapur, MD, FSCAI, FAHA, FACC

Professor of Medicine
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure(s): Abiomed / Johnson & Johnson: Employee (Ongoing)

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Daniel Burkhoff, MD, PhD: Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Navin K. Kapur, MD, FSCAI, FAHA, FACC: Abiomed / Johnson & Johnson: Employee (Ongoing)